Video Latest - ecancer

Cured AML patients generate anti-tumour antibodies that kill AML blasts

Dr Mette Hazenberg - Academic Medical Center, Amsterdam, The Netherlands

6 Jul 2016

Monitoring the cancer genome in plasma using circulating tumour DNA

Dr Nitzan Rosenfeld - Cancer Research UK Cambridge Institute, Cambridge, UK

5 Jul 2016

Models and critical preclinical data shaping personal therapy

Prof Brian Leyland-Jones - Avera McKennan Cancer Institute, Sioux-Falls, USA

5 Jul 2016

Cancer organoids

Dr Robert Vries - Hubrecht Organoid Technology, Utrecht, The Netherlands

5 Jul 2016

Serum miRNAs as diagnostic tools in GI malignancies

Dr Ajay Goel - Baylor University Medical Center, Waco, USA

4 Jul 2016

Combination trial designs: efficient, effective and tolerable regimens

Dr Susan Galbraith – AstraZeneca, Macclesfield, UK

4 Jul 2016

Patient perspectives in precision medicine: 'No innovation about us without us'

Dr Francesco de Lorenzo - European Cancer Patient Coalition, Brussels, Belgium

4 Jul 2016

Preclinical strategies for precision medicine in colorectal cancer

Dr Livio Trusolino - Candiolo Cancer Institute, Turin, Italy

4 Jul 2016

WIN 2016 highlights: Emerging technologies

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

4 Jul 2016

Critique of the SHIVA trial

Dr Razelle Kurzrock - University of California, San Diego, USA

4 Jul 2016

Personalising breast cancer therapy

Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center, Houston, USA

4 Jul 2016

Affordable next generation sequencing to support decision making

Dr Elaine Mardis - Washington University, St Louis, USA

1 Jul 2016

Video